QR Code

The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer CareResearch in context

Background: Using patient-derived xenografts (PDXs) to assess chemosensitivity to anti-cancer agents in real-time may improve cancer care by enabling individualized clinical decision-making. However, it is unknown whether this new approach will be met with acceptance by patients, family and communit...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: C.E. Wakefield, E.L. Doolan, J.E. Fardell, C. Signorelli, V.F. Quinn, K.M. Tucker, A.F. Patenaude, G.M. Marshall, R.B. Lock, G. Georgiou, R.J. Cohn
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2018-11-01
Rangatū:EBioMedicine
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S235239641830478X
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!